Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Accelerate Diagnostics Stock Quote

Accelerate Diagnostics (NASDAQ: AXDX)

$0.75
(1.8%)
$0.01
Price as of April 18, 2024, 2:23 p.m. ET

Accelerate Diagnostics Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
AXDX -89.17% -99.59% -66.72% -54%
S&P +20.88% +72.88% +11.56% +1,493%

Accelerate Diagnostics Company Info

Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The firm's products include Accelerate Pheno and Accelerate PhenoTest. The company was founded in 1982 and is headquartered in Tucson, AZ.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.